Angebote zu "Abo-Incompatible" (19 Treffer)

Kategorien

Shops

ABO-incompatible Organ Transplantation
130,39 € *
ggf. zzgl. Versand

Erscheinungsdatum: 06.03.2019, Medium: Buch, Einband: Gebunden, Titel: ABO-incompatible Organ Transplantation, Auflage: 2019, Redaktion: Wang, Yi, Verlag: Springer-Verlag GmbH // Springer Singapore, Sprache: Englisch, Schlagworte: Chirurgie // Plastische Chirurgie // Operation // medizinisch // Transplantation // Medizin // Spezialgebiete // MEDICAL // Surgery // General // Transplantationschirurgie // Klinische und Innere Medizin // Medizinische Spezialgebiete, Rubrik: Medizin // Andere Fachgebiete, Seiten: 274, Abbildungen: 7 schwarz-weiße und 5 farbige Abbildungen, 20 farbige Tabellen, Bibliographie, Informationen: Book, Gewicht: 641 gr, Verkäufer: averdo

Anbieter: averdo
Stand: 27.10.2020
Zum Angebot
ABO-incompatible Organ Transplantation
138,99 € *
ggf. zzgl. Versand

ABO-incompatible Organ Transplantation ab 138.99 € als pdf eBook: . Aus dem Bereich: eBooks, Fachthemen & Wissenschaft, Medizin,

Anbieter: hugendubel
Stand: 27.10.2020
Zum Angebot
ABO-incompatible Organ Transplantation
149,99 € *
ggf. zzgl. Versand

ABO-incompatible Organ Transplantation ab 149.99 € als gebundene Ausgabe: Auflage 2019. Aus dem Bereich: Bücher, Wissenschaft, Medizin,

Anbieter: hugendubel
Stand: 27.10.2020
Zum Angebot
ABO-incompatible Organ Transplantation
149,99 € *
ggf. zzgl. Versand

ABO-incompatible Organ Transplantation ab 149.99 EURO Auflage 2019

Anbieter: ebook.de
Stand: 27.10.2020
Zum Angebot
ABO-incompatible Organ Transplantation
138,99 € *
ggf. zzgl. Versand

ABO-incompatible Organ Transplantation ab 138.99 EURO

Anbieter: ebook.de
Stand: 27.10.2020
Zum Angebot
Humoral Immunity in Kidney Transplantation
81,84 € *
ggf. zzgl. Versand

As recent advances in immunosuppression and apheresis techniques have opened new avenues for the management of humoral immunity, interest in ABO-incompatible kidney transplantation has been renewed. Moreover, new screening techniques - such as the single antigen bead assay - allow for the detection and definition of very low levels of alloantibody, which has had a positive impact on the treatment possibilities in highly sensitized adult patients with end-stage renal disease. But despite these advances, a theoretical rationale is still missing for both the decision to transplant a sensitized patient and the classification of the transplant as low, medium or high risk. There is also no uniform approach with regard to pre-transplant desensitization protocols, and it is unclear whether particular post-transplant immunosuppression will be required and what would be the best combination treatment. Last but not least, the frequency and actual clinical impact of alloantibodies developed after transplantation on short- and long-term graft survival need to be ascertained. Aimed especially at the clinician, this publication presents recent insights in the characterization and pathogenetic role of humoral immunity in chronic allograft injury and investigates the perspectives for novel immunosuppressive therapies to control antibody production after transplantation.

Anbieter: Dodax
Stand: 27.10.2020
Zum Angebot
Marginal Donors
131,96 € *
ggf. zzgl. Versand

In response to persistent donor organ shortages, organs from marginal donors, such as expanded criteria donors (ECD) and donation after cardiac death (DCD) donors, are now accepted and have been successfully transplanted, reducing the waiting times for transplantation. Especially in Japan, transplantation of DCD kidneys has a relatively long history because of the difficulty or lack of national consensus in accepting brain death, which has made it possible to accumulate considerable clinical experience. Thus, the current organ shortage has stimulated interest in the use of marginal donors for transplantation. On the other hand, however, it is known that these organs have a high rate of delayed graft function and a more complicated postoperative course. These drawbacks have created the greatest clinical challenge in transplantation to date because of the current shortage and limitations of donors using ECD and DCD.This book, prepared by distinguished authorities in their fields, is intended for clinicians and researchers. It highlights the use of marginal donors as a comparatively novel source of transplantation organs and provides a thorough overview of marginal donors from their historical origins to recent clinical applications, including the state-of-the-art science of organ/donor management, procurement, and preservation. Also provided is valuable information on ABO-incompatible donors which extend the availability of donor sources. Each chapter offers an individual analysis of the optimal requirements for the safe management and preservation of organs, including the heart, lung, liver, kidney, pancreas, and pancreatic islets.

Anbieter: Dodax
Stand: 27.10.2020
Zum Angebot
ABO-incompatible Organ Transplantation
126,48 € *
ggf. zzgl. Versand

This book introduces the clinical application of ABO-incompatible transplantation. In the first part, it starts with the history, blood group antigen, antibody associated with ABO blood type, pathophysiology and pathology and related knowledge. In the second part, it covers clinical experience sharing of ABO-incompatible of heart, liver, lung and kidney transplantation. It provides a systematic methodologies and protocols.

Anbieter: Dodax
Stand: 27.10.2020
Zum Angebot
Marginal Donors
151,00 CHF *
ggf. zzgl. Versand

In response to persistent donor organ shortages, organs from marginal donors, such as expanded criteria donors (ECD) and donation after cardiac death (DCD) donors, are now accepted and have been successfully transplanted, reducing the waiting times for transplantation. Especially in Japan, transplantation of DCD kidneys has a relatively long history because of the difficulty or lack of national consensus in accepting brain death, which has made it possible to accumulate considerable clinical experience. Thus, the current organ shortage has stimulated interest in the use of marginal donors for transplantation. On the other hand, however, it is known that these organs have a high rate of delayed graft function and a more complicated postoperative course. These drawbacks have created the greatest clinical challenge in transplantation to date because of the current shortage and limitations of donors using ECD and DCD. This book, prepared by distinguished authorities in their fields, is intended for clinicians and researchers. It highlights the use of marginal donors as a comparatively novel source of transplantation organs and provides a thorough overview of marginal donors from their historical origins to recent clinical applications, including the state-of-the-art science of organ/donor management, procurement, and preservation. Also provided is valuable information on ABO-incompatible donors which extend the availability of donor sources. Each chapter offers an individual analysis of the optimal requirements for the safe management and preservation of organs, including the heart, lung, liver, kidney, pancreas, and pancreatic islets.

Anbieter: Orell Fuessli CH
Stand: 27.10.2020
Zum Angebot